<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Info | wechat-feeds</title><link>http://MzU2MTcxOTAwMw.favicon.privacyhide.com/favicon.ico</link><description>传递医药信息，分享资源数据！充电5分钟，吹牛2小时！</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 21 Feb 2021 16:21:09 +0800</pubDate><image><url>http://MzU2MTcxOTAwMw.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Info | wechat-feeds</title><link>http://MzU2MTcxOTAwMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>百奥泰科创板上市1周年！近日终止一项在研ADC项目，已投入2.26亿元</title><link>https://mp.weixin.qq.com/s/75sqOo3DI2V2-_SByELMNA</link><description></description><content:encoded><![CDATA[百奥泰科创板上市1周年！近日终止一项在研ADC项目，已投入2.26亿元]]></content:encoded><pubDate>Sun, 21 Feb 2021 14:10:45 +0800</pubDate></item><item><title>芦可替尼新剂型获FDA优先审评，2020年全球销售额32.76亿美元</title><link>https://mp.weixin.qq.com/s/_HmvkgLHUoBE-4TTfsHxsA</link><description></description><content:encoded><![CDATA[芦可替尼新剂型获FDA优先审评，2020年全球销售额32.76亿美元]]></content:encoded><pubDate>Sat, 20 Feb 2021 17:41:19 +0800</pubDate></item><item><title>安斯泰来潜在first-in-class口服非激素疗法治疗更年期潮热III期研究结果积极</title><link>https://mp.weixin.qq.com/s/xHFm6zEK__X04McfHnMRaA</link><description></description><content:encoded><![CDATA[安斯泰来潜在first-in-class口服非激素疗法治疗更年期潮热III期研究结果积极]]></content:encoded><pubDate>Sat, 20 Feb 2021 17:41:19 +0800</pubDate></item><item><title>默沙东HIF-2α抑制剂临床申请获受理</title><link>https://mp.weixin.qq.com/s/E5WeczOtZVQizslga3gzSg</link><description></description><content:encoded><![CDATA[默沙东HIF-2α抑制剂临床申请获受理]]></content:encoded><pubDate>Sat, 20 Feb 2021 17:41:19 +0800</pubDate></item><item><title>传奇生物公布2020年初步业绩</title><link>https://mp.weixin.qq.com/s/muyfxrA36okS3-lMsrkQnw</link><description></description><content:encoded><![CDATA[传奇生物公布2020年初步业绩]]></content:encoded><pubDate>Sat, 20 Feb 2021 17:41:19 +0800</pubDate></item><item><title>恒瑞宣布NMPA批准氟唑帕利单药或联合阿帕替尼治疗转移性去势抵抗性前列腺癌II期试验</title><link>https://mp.weixin.qq.com/s/knRM0BRliKsbQZCR6k4IcA</link><description></description><content:encoded><![CDATA[恒瑞宣布NMPA批准氟唑帕利单药或联合阿帕替尼治疗转移性去势抵抗性前列腺癌II期试验]]></content:encoded><pubDate>Sat, 20 Feb 2021 17:41:19 +0800</pubDate></item><item><title>特瑞普利单抗第2个适应症获批，治疗鼻咽癌</title><link>https://mp.weixin.qq.com/s/9Pti3MVKGB7hHpeugoWvqA</link><description></description><content:encoded><![CDATA[特瑞普利单抗第2个适应症获批，治疗鼻咽癌]]></content:encoded><pubDate>Fri, 19 Feb 2021 18:17:06 +0800</pubDate></item><item><title>国产1类银屑病新药「本维莫德乳膏」长期用药III期研究获积极结果</title><link>https://mp.weixin.qq.com/s/zd3CB-Z-r2bQTfzBWlz9Ow</link><description></description><content:encoded><![CDATA[国产1类银屑病新药「本维莫德乳膏」长期用药III期研究获积极结果]]></content:encoded><pubDate>Fri, 19 Feb 2021 18:17:06 +0800</pubDate></item><item><title>燧坤智能与艾博生物达成战略合作</title><link>https://mp.weixin.qq.com/s/n17hmgUE6uvvsNUFKJkj6w</link><description></description><content:encoded><![CDATA[燧坤智能与艾博生物达成战略合作]]></content:encoded><pubDate>Fri, 19 Feb 2021 18:17:06 +0800</pubDate></item><item><title>预防孕妇新冠感染，辉瑞/BioNTech mRNA疫苗完成首批受试者接种</title><link>https://mp.weixin.qq.com/s/pEkD4iDtYILGU1FHLsc59w</link><description></description><content:encoded><![CDATA[预防孕妇新冠感染，辉瑞/BioNTech mRNA疫苗完成首批受试者接种]]></content:encoded><pubDate>Fri, 19 Feb 2021 18:17:06 +0800</pubDate></item><item><title>《医疗保障基金使用监督管理条例》发布，5月1日起施行</title><link>https://mp.weixin.qq.com/s/tlc1QrPauxdBwtfI60CYcA</link><description></description><content:encoded><![CDATA[《医疗保障基金使用监督管理条例》发布，5月1日起施行]]></content:encoded><pubDate>Fri, 19 Feb 2021 18:17:06 +0800</pubDate></item><item><title>Stroke：有效改善缺血性脑卒中患者功能结局！依达拉奉右莰醇Ⅲ期临床数据发表</title><link>https://mp.weixin.qq.com/s/RZqY1HcIeoAbe5WVHWkUNw</link><description></description><content:encoded><![CDATA[Stroke：有效改善缺血性脑卒中患者功能结局！依达拉奉右莰醇Ⅲ期临床数据发表]]></content:encoded><pubDate>Wed, 17 Feb 2021 11:09:05 +0800</pubDate></item><item><title>心衰新药Entresto新适应证获批，覆盖人群扩大一倍！全球销售额25亿美元</title><link>https://mp.weixin.qq.com/s/GIiUp5draU2r2NZkU50KFA</link><description></description><content:encoded><![CDATA[心衰新药Entresto新适应证获批，覆盖人群扩大一倍！全球销售额25亿美元]]></content:encoded><pubDate>Wed, 17 Feb 2021 11:09:05 +0800</pubDate></item><item><title>医药圈10对知名创业眷侣</title><link>https://mp.weixin.qq.com/s/K-DOuZaCnCkwnCGiulEfLg</link><description></description><content:encoded><![CDATA[医药圈10对知名创业眷侣]]></content:encoded><pubDate>Sun, 14 Feb 2021 10:30:25 +0800</pubDate></item><item><title>FDA批准首个化疗骨髓保护新药Trilaciclib！先声药业拥有中国权益</title><link>https://mp.weixin.qq.com/s/y0yZzfkFnQGnpU8epeZOIQ</link><description></description><content:encoded><![CDATA[FDA批准首个化疗骨髓保护新药Trilaciclib！先声药业拥有中国权益]]></content:encoded><pubDate>Sat, 13 Feb 2021 10:15:57 +0800</pubDate></item><item><title>宫颈癌First in class抗体偶联药物申报上市！单药治疗ORR达24%</title><link>https://mp.weixin.qq.com/s/y8ZYKVJPsf1MNxdH45yYTQ</link><description></description><content:encoded><![CDATA[宫颈癌First in class抗体偶联药物申报上市！单药治疗ORR达24%]]></content:encoded><pubDate>Thu, 11 Feb 2021 11:35:11 +0800</pubDate></item><item><title>信达生物/驯鹿医疗CAR-T疗法获CDE拟突破性疗法认定</title><link>https://mp.weixin.qq.com/s/YAcdw3TS2v8HelGVxeIl8Q</link><description></description><content:encoded><![CDATA[信达生物/驯鹿医疗CAR-T疗法获CDE拟突破性疗法认定]]></content:encoded><pubDate>Thu, 11 Feb 2021 11:35:11 +0800</pubDate></item><item><title>FDA紧急授权君实与礼来的中和抗体联合治疗COVID-19</title><link>https://mp.weixin.qq.com/s/-2pOdu-MpCvBCALo5g8Naw</link><description></description><content:encoded><![CDATA[FDA紧急授权君实与礼来的中和抗体联合治疗COVID-19]]></content:encoded><pubDate>Wed, 10 Feb 2021 12:26:46 +0800</pubDate></item><item><title>天演药业昨晚在美国纳斯达克IPO</title><link>https://mp.weixin.qq.com/s/p0WRs2wS1elXVHdLHuY9tg</link><description></description><content:encoded><![CDATA[天演药业昨晚在美国纳斯达克IPO]]></content:encoded><pubDate>Wed, 10 Feb 2021 12:26:46 +0800</pubDate></item><item><title>2021年1月FDA批准的新药</title><link>https://mp.weixin.qq.com/s/Z8C_ou9D3tBcIeKs-b2Bow</link><description></description><content:encoded><![CDATA[2021年1月FDA批准的新药]]></content:encoded><pubDate>Mon, 08 Feb 2021 17:53:33 +0800</pubDate></item></channel></rss>